Related references
Note: Only part of the references are listed.Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
Jane R. Kenny et al.
DRUG METABOLISM AND DISPOSITION (2018)
Isotretinoin administration improves sperm production in men with infertility from oligoasthenozoospermia: a pilot study
J. K. Amory et al.
ANDROLOGY (2017)
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
Niresh Hariparsad et al.
DRUG METABOLISM AND DISPOSITION (2017)
Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice
Xian Pan et al.
DRUG METABOLISM AND DISPOSITION (2017)
In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation
Jennifer E. Sager et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Evaluation of Disease-Mediated Therapeutic Protein-Drug Interactions Between an Anti-Interleukin-6 Monoclonal Antibody (Sirukumab) and Cytochrome P450 Activities in a Phase 1 Study in Patients With Rheumatoid Arthritis Using a Cocktail Approach
Yanli Zhuang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice
Xian Pan et al.
MOLECULAR PHARMACOLOGY (2015)
Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner
Xian Pan et al.
DRUG METABOLISM AND DISPOSITION (2015)
All-trans retinoic acid regulates hepatic bile acid homeostasis
Fan Yang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma
Poonam Sonawane et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Retinoic acid regulates several genes in bile acid and lipid metabolism via upregulation of small heterodimer partner in hepatocytes
Abulkhair Mamoon et al.
GENE (2014)
Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice
Kwi Hye Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Investigational Small-Molecule Drug Selectively Suppresses Constitutive CYP2B6 Activity at the Gene Transcription Level: Physiologically Based Pharmacokinetic Model Assessment of Clinical Drug Interaction Risk
Maciej J. Zamek-Gliszczynski et al.
DRUG METABOLISM AND DISPOSITION (2014)
Hepatic Cyp2d and Cyp26a1 mRNAs and Activities Are Increased During Mouse Pregnancy
Ariel R. Topletz et al.
DRUG METABOLISM AND DISPOSITION (2013)
Effects of Interleukin 1β (IL-1β) and IL-1β/Interleukin 6 (IL-6) Combinations on Drug Metabolizing Enzymes in Human Hepatocyte Culture
Leslie J. Dickmann et al.
CURRENT DRUG METABOLISM (2012)
An 'all-inclusive' 96-well cytochrome P450 induction method: Measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes
Jason S. Halladay et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Prediction of Relative In Vivo Metabolite Exposure from In Vitro Data Using Two Model Drugs: Dextromethorphan and Omeprazole
Justin D. Lutz et al.
DRUG METABOLISM AND DISPOSITION (2012)
Disease-Drug-Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis
C. Schmitt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture
Leslie J. Dickmann et al.
DRUG METABOLISM AND DISPOSITION (2011)
Retinoids activate RXR/CAR-mediated pathway and induce CYP3A
Shiyong Chen et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data
I. Templeton et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms
Shi-Ying Cai et al.
JOURNAL OF LIPID RESEARCH (2010)
Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures
Choon-Myung Lee et al.
DRUG METABOLISM AND DISPOSITION (2009)
Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway
Kun Wang et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2008)
Retinoic acid responsive genes in the murine hepatocyte cell line AML 12
Abulkhair Mamoon et al.
GENE (2008)
Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro
JM Baron et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Induction of CYP1A in the beagle dog by an inhibitor of kinase insert domain-containing receptor: Differential effects in vitro and in vivo on mRNA and functional activity
CR Gibson et al.
DRUG METABOLISM AND DISPOSITION (2005)